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Introduction
Sarcoidosis is a multisystemic granulomatous disease
of unknown origin, characterized by widespread non-
caseating epithelioid cell granuloma. Major organs
involved are the chest, skin, eyes, liver, extrapulmonary
lymph nodes and many other places in the body. The
course of sarcoidosis ranges from asymptomatic to
severe and even lethal disease. It occurs worldwide
but is predominant in certain ethnic and racial groups
such as US blacks, Scandinavian and Irish white peo-
ple. In contrast, the disease is rare in India, Southeast
Asia, New Zealand and China.1,2
Uveitis is thought to be the most common ocular
manifestation in sarcoidosis.3–5 It may progress to se-
vere visual impairment or even blindness. Uveitis with
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sarcoidosis occurs in more than 10% of uveitis patients
in many areas, including some areas of the United States,
Japan and the cities of Amsterdam and Rotterdam.3
But it was absent in a large study that included 1,752
Chinese patients with uveitis.6 Also, as noted in our
previous report,7 uveitis with sarcoidosis was found in
just 1 in 240 cases from 1984 to 1986.
The manifestations of uveitis in sarcoidosis are vari-
able in certain ethnic and racial groups. A high fre-
quency of anterior uveitis is noted mainly in studies
where the majority of patients are black.8,9 In contrast,
posterior uveitis is the most common localization of
sarcoid uveitis in white patients.8,10 Panuveitis is thought
to be the most common type in Japanese,11 but there
is no information on Chinese patients.
However, there has been a notable increase in the
number of patients with uveitis that consequently led
to the diagnosis of sarcoidosis recently.12 The present
study aimed to analyze the clinical demographics of
uveitis with biopsy-proven sarcoidosis in Chinese
patients.
Methods
Data collection for the purpose of this study was
approved by the institutional review board of Taipei
Veterans General Hospital, Taipei, Taiwan. All patients
included in the study were Chinese who consecutively
visited the uveitis clinic at Taipei Veterans General
Hospital during a period of 20 years between 1986
and 2005. A retrospective chart review was performed.
All patients were observed for at least 6 months. We
confined our review to patients seen by 1 author only
(Chung YM) for consistency.
Diagnosis of sarcoidosis was made on the basis of
the presence of non-caseating granuloma on tissue
biopsy together with a compatible picture of uveitis.
Other granuloma-forming processes, such as tubercu-
losis, fungal infection, and various foreign bodies, had
been excluded.4,13
Each patient referred to this clinic had a special
chart that was used to record the detailed data con-
cerning uveitis history, results from complete oph-
thalmologic examinations and associated systemic
conditions. All patients were referred by either a gen-
eral ophthalmologist or a pulmonologist. When the
manifestations of uveitis were highly suggestive of sar-
coidosis, a chest radiograph (CXR) was performed. In
addition, since 2002, patients also received chest com-
puted tomography (CT). The modified Scadding classi-
fication of lung involvement has been widely accepted.
Stage 0 means no abnormality; Stage I, lymph node
enlargement; Stage II, lymph node enlargement
accompanied by pulmonary infiltration; Stage III, pul-
monary infiltration with no lymph node enlargement;
and Stage IV, evidence of pulmonary fibrosis with
retraction of the hilar areas cephalad, cystic change
and bullae.13
Histologic proof of the diagnosis was frequently
obtained from biopsy of the lung by bronchoscopy or
CT-guided examination, mediastinal lymph node by
mediastinoscopy, liver or spleen by sonoguided meth-
ods. Conjunctival biopsy was by a blind method.12
Some patients received biopsy at more than 1 site.
Uveitis was classified as anterior, intermediate, pos-
terior and panuveitis by the Standardization of Uveitis
Nomenclature (SUN) working group.14 Anterior uveitis
was defined as inflammation of the anterior segment
presenting medium to large mutton-fat-like keratic
precipitates, peripheral anterior synechiae, posterior
synechiae, iris nodule and so on. Intermediate uveitis
was defined as inflammation of the intermediate seg-
ment presenting vitreous opacity such as snowballs,
snowbank and so on. Posterior uveitis was defined as
inflammation of the retina and choroid presenting with
periphlebitis, candle-wax drippings along the retinal
veins, chorioretinal exudates, choroidal granuloma
and so on. Panuveitis was defined as inflammation of
all segments.
Results
A total of 60 uveitis patients with biopsy-proven sar-
coidosis were identified during the 20-year-period from
1986 to 2005. There was a marked female predomi-
nance, with a male-to-female ratio of 1:6.5 (male 8,
female 52). The distribution of the patients by year is
shown in Figure 1. Forty-four patients (73%) were
found in the last 4 years.
Age and sex distribution of uveitis onset are shown
in Figure 2. The mean age at uveitis onset was 47.7 ±
14.7 years (range, 21–76 years); mean age was 46.4 ±
21.3 in males and 47.9 ± 13.7 in females. There was
no gender difference (p = 0.913). The distribution of
age at uveitis onset showed a peak incidence in the 6th
decade of life (Figure 2).
The initial symptoms of these 60 patients were
uveitis in 41 patients (68.3%), accidental finding by 
a health examination in 5 patients (8.3%), skin lesions
in 4 patients (6.7%), constitutional conditions in-
cluding fever, leukopenia and body weight loss in 
4 patients (6.7%), neck mass lesion in 3 patients (5.0%),
respiratory problems in 2 patients (3.3%), and neuro-
logic symptom in 1 patient.
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There were 81 positive biopsy sites, including 45
patients with 1 positive site, 9 patients with 2 positive
sites, and 6 patients with 3 positive sites. The most
common positive biopsy sites were mediastinal lymph
nodes in 34 patients (56.7%), followed by lung in 
14 patients (23.3%), conjunctiva in 13 patients (21.7%),
skin in 10 patients (16.7%), extrathoracic lymph nodes
in 6 patients (10.0%), liver in 1, spleen in 1, bone
marrow in 1 and parotid gland in 1 patient.
Comparison of stages of CXR and CT in 44
patients who presented since 2002 is shown in Table 1.
Twenty (90.9%) of 22 patients with CXR stage 0
showed ≥ stage 1 on CT.
Frequency of the manifestations of uveitis show-
ing isolated anterior uveitis occurred in 2 patients
(3.3%), isolated posterior uveitis in 8 patients (13.3%),
intermediate and posterior uveitis (i.e. anterior uveitis
sparing) in 16 patients (26.7%) and panuveitis (gran-
ulomatous) in 34 patients (56.7%). Of the 60 patients,
there was bilateral eye involvement in 54 (90%).
Discussion
Sarcoidosis is rarely seen among Chinese. The first
documented case of sarcoidosis in Chinese was reported
by Tsou et al in 1958.15 In the English literature, the
first case report was by Hsing et al in 1964.16 Up to
1981, there were only 15 published cases, including 4
reported by Nandi et al in a literature review.17 Among
mainland Chinese, where the total population has
reached 1.3 billion, only about 300 cases have been
reported up to 1982.18 Even in the past 20 years,
there is still a relatively small number of cases with
Table 1. Comparisons of chest condition in stages of chest X-ray
(CXR) and chest computed tomography (CT) (n = 44)
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Figure 1. Distribution of the 60 uveitis patients with biopsy-proven sarcoidosis by year (1986–2005).
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Figure 2. Age and sex distribution of uveitis onset among 60
patients with biopsy-proven sarcoidosis.
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biopsy-proven sarcoidosis reported in Chinese.19–24
Taiwan, an island with more than 23,000,000 inhabi-
tants, is situated at the east-southern coast of mainland
China. Nearly all of its inhabitants have come from
mainland China.
The pattern of uveitis in a given population is
strongly influenced by genetic, geographic and envi-
ronmental factors. Sarcoidosis has come to be the
most common type of uveitis rather than Behcet’s dis-
ease and Vogt-Koyanagi-Harada’s disease in Japan.25,26
Our uveitis clinic, established in 1984, is the first in a
Chinese area.7 The incidence of uveitis with biopsy-
proven sarcoidosis was about 0–2% of the total number
of uveitis patients per year before 2002, and a marked
increase to 4–6% was found since 2002. One of the
causes of this increase is the performance of chest CT.
Chest CT can be useful to discover mediastinal lym-
phadenopathy and other lesions suggestive of sarcoido-
sis, as well as to help guide tissue confirmation.27 In
this study, 20 (90.9%) of 22 patients with CXR stage
0 showed ≥ stage 1 on CT. This means that mediasti-
nal lymphadenopathy and other lesions suggestive of
sarcoidosis cannot be revealed solely by CXR. Further
examination with CT is necessary in patients with pecu-
liar uveitis features indicative of sarcoidosis.
Generally, an accidental finding by a health exami-
nation of CXR films or mass screening CXR program
is still thought to be the major way of detecting sar-
coidosis. Eye manifestation, especially uveitis, as the ini-
tial symptom of sarcoidosis is increasing.28,29 A survey
by the Diffuse Pulmonary Disease Research Committee
of Japan showed that the prevalence of cases with
ocular lesions has markedly increased in recent years,
while the proportion of patients with bilateral hilar
lymphadenopathy or pulmonary involvement detected
by CXR mass survey has decreased.30
A definite diagnosis of sarcoidosis requires demon-
stration of non-caseating granuloma and other granu-
loma-forming processes excluded on tissue biopsy.
Transbronchial and mediastinal biopsy are both the
most common tissue-proved sites in sarcoidosis, because
the most common involved area of sarcoidosis is in
the chest. The same results were found in this study.
On the other hand, conjunctiva was also a common site
in this study. A blind and bilateral conjunctival biopsy,
due to its ease, safety and specificity, is strongly sug-
gested. The positive rate of patients with pathologic
findings suggesting sarcoidosis in conjunctival biopsy
was 38–55%.12,31,32
Female predominance in uveitis with sarcoidosis is
well founded.4 Our data showed an absolute female
predominance, with a female-to-male ratio of 6.5, which
was higher than for other ethnicities.4,5,25 Two peaks
of incidence reported for sarcoid uveitis were at the
age of 20–30 years and 50–60 years.4 In this study, the
6th decade was the most common onset age.
The frequency of anatomically classified form of
uveitis with sarcoidosis is variable. Anterior uveitis is
considered the most common.5 In contrast, the pos-
terior segment is the most common localization of
sarcoid uveitis in white patients, specifically in elderly
female patients.4,8 In this study, the posterior segment
was the most commonly involved area. The situation
is similar to that in whites.
The spectrum of intraocular inflammation in sar-
coidosis is wide.5,33,34 Mutton-fat keratic precipitates/
iris nodules, trabecular meshwork nodules/tent-shaped
peripheral anterior synechiae, snowball vitreous opaci-
ties, nodular periphlebitis and multiple chorioretinal
lesions are considered pathognomonic manifestations
in uveitis with sarcoidosis in Japan.34 Anterior uveitis
including granulomatous and non-granulomatous
inflammation is considered the most common type of
uveitis in biopsy-proven sarcoidosis.5 In contrast, panu-
veitis was the most rare type.5 The situation is much
different from the results in our study. Inflammation
of the posterior segment is the most common localiza-
tion of sarcoid uveitis in white patients, specifically in
elderly female patients.4,8 In this study, the posterior
segment of the eye ball was also found to be the most
commonly involved area. The situation in Chinese is
similar to that in whites.
In summary, this study presents the largest reported
group of uveitis patients with biopsy-proven sarcoido-
sis in the Chinese population. The marked increase in
the number of patients after 2002 is mostly due to the
performance of CT in the normal CXR patients. Female
predominance and peak incidence of uveitis onset in
the 6th decade of life were found. The posterior seg-
ment was the most commonly involved area. The sit-
uation is similar to that in whites. Our uveitis clinic is
the first to be established in a Chinese area.7 This infor-
mation on uveitis with biopsy-proven sarcoidosis in the
Chinese population is constructive.
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